.

... ..

 

November 16 2007

A new paper, "The effects of hyperbaric oxygen therapy on oxidative
stress, inflammation, and symptoms in children with autism: an open-
label pilot study" has just been published in the peer reviewed
medical journal BioMed Central Pediatrics. A pdf of this paper is
available for free here
www.biomedcentral.com/content/pdf/1471-2431-7-36.pdf

Please go and download the article. If you want others to also have
the article, I encourage you to send the link as opposed to the pdf
itself.

This is important, and here's why. Unlike the better-known,
traditional titles (such as a New England Journal of Medicine), where
it might take two or three years to get essential medical data
published, this particular journal (BioMed Central Pediatrics) will
publish more articles based on demand--as measured by pdf downloads.
This is huge because it points a finger at where more research
dollars should be spent.

The primary authors are Dan and Lanier Rossignol. Dan is an MD and
Lanier is an RN. They are parents of two boys diagnosed with ASD;
however, when I last spoke with them, the oldest has improved
tremendously and the youngest is almost completely cured of ASD--
primarily due to HBOT.

Nobody could be more personally motivated and totally dedicated to
finding a cure for autism than Dan and Lanier Rossignol. Please
support them in their efforts. Based on the evidence, I believe an
autism cure will also lead to a cerebral palsy cure.

This paper closely examines the two camps in hyperbarics. Which
provides greater efficacy 1.3 ATA ambient air or 1.5 ATA with 100%
oxygen?

Also, recent court decisions now require Georgia Medicaid to
reimburse HBOT, and Georgia Medicaid has no more avenues of appeal.
These decisions can be applied to autistic children as well as cp
children. This paper further supports Medicaid reimbursement of HBOT
for autism.

David Freels
2948 Windfield Circle
Tucker, GA 30084-6714
770-491-6776 (phone)
404-725-4520 (cell)
815-366-7962 (fax)

To join the discussion group Medicaid for HBOT, click here (Free Yahoo account required)
http://health.groups.yahoo.com/group/medicaidforhbot


The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study

www.biomedcentral.com/content/pdf/1471-2431-7-36.pdf

Summary:

A pilot study of the effect of Hyperbaric Oxygen Therapy on autism symptoms, oxidative stress and inflammation has been published in BMC Pediatrics. In The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study Daniel A Rossignol , Lanier W Rossignol , S. Jill James , Stepan Melnyk and Elizabeth Mumper report their findings and conclusions from a study of 18 children with autism aged 3-16 who underwent 40 hyperbaric sessions of 45 minutes duration each at either 1.5 atmospheres (atm) and 100% oxygen, or at 1.3 atm and 24% oxygen. On safety issues the authors report that maximum pressure of 1.5 atm with up to 100% oxygen was safe and well tolerated. In terms of improvements the report indicates, as set out in the abstract, that "HBOT significantly decreased inflammation as measured by CRP levels.

Parental observations support anecdotal accounts of improvement in several domains of autism." The authors of the paper note that this was an "open label" study and "definitive statements regarding the efficacy of HBOT for the treatment of individuals with autism must await results from double-blind, controlled trials".


Home

vitaDive
Benefits Studies Articles Videos Books Models Contact